Stay updated on GTX-102 Safety in Angelman Syndrome Kids Clinical Trial
Sign up to get notified when there's something new on the GTX-102 Safety in Angelman Syndrome Kids Clinical Trial page.

Latest updates to the GTX-102 Safety in Angelman Syndrome Kids Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedThe site footer revision label changed from v3.7.2 to v3.8.0.SummaryDifference0.1%

- Check19 days agoChange DetectedA banner announces NIH’s website transition and says the agency is using “Super Intelligence” in place of “Artificial Intelligence” during the change.SummaryDifference0.4%

- Check26 days agoChange DetectedThe ClinicalTrials.gov site footer revision changed from v3.7.1 to v3.7.2.SummaryDifference0.1%

- Check33 days agoChange DetectedThe ClinicalTrials.gov page footer now identifies the site as revision v3.7.1 instead of v3.7.0.SummaryDifference0.1%

- Check54 days agoChange DetectedThe history view now displays the latest revision as v3.7.0, replacing the previous v3.6.6 in the revision list. This indicates an update to the record's metadata rather than changes to the study data.SummaryDifference0.1%

- Check75 days agoChange DetectedThe page history now displays Revision: v3.6.6, replacing the previous v3.6.5.SummaryDifference0.1%

Stay in the know with updates to GTX-102 Safety in Angelman Syndrome Kids Clinical Trial
Enter your email address, and we'll notify you when there's something new on the GTX-102 Safety in Angelman Syndrome Kids Clinical Trial page.